Results 231 to 240 of about 38,480 (291)

Tightening Our Belts in the New Healthcare Economy [PDF]

, 2013
Pizzi, Laura, PharmD,MPH
core   +1 more source

From Algorithms to Biomarkers: Toward Personalized Management of Venous Thromboembolism. [PDF]

J Clin Med
Boccatonda A.
europepmc   +1 more source

Safety and effectiveness of Rivaroxaban, Dabigatran and Apixaban in patients with non-valvular atrial fibrillation for stroke prophylaxis. [PDF]

BMC Neurol
Tanoğlu C, Ersoy A.
europepmc   +1 more source

Rapid Screening of Anticoagulation Compounds for Biological Target-Associated Adverse Effects Using a Deep-Learning Framework in the Management of Atrial Fibrillation. [PDF]

Bioengineering (Basel)
Dong T, Llewellyn R, Hezzell M, Angelini GD.   +3 more
europepmc   +1 more source

Appropriateness of Apixaban Dosing to Prevent Stroke in Patients with Atrial Fibrillation: A Pilot Study

, 2016
Stephanie Carlin, Jennifer Pickering, Sam Schulman   +2 more
openalex   +2 more sources

A photodistributed rash in a patient on apixaban

JAAD Case Reports
Benjamin Donald Henson, BS, Rachel B. Lee, MD   +1 more
openaire   +2 more sources

Analysis of Upper Gastrointestinal Adverse Events Associated with Oral Anticoagulants and Potential Drug Interactions with Cardiovascular Drugs: Exploratory Study Using FDA Adverse Event Reporting System. [PDF]

Pharmaceuticals (Basel)
Cheon S, Park J, Oh D, Kim YS, Chung JE.
europepmc   +1 more source

Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart Disease. [PDF]

Clin Pharmacol Ther
Ajavon-Hartmann A, Jarugula P, Back H, Obianom O, Ludwig E, Crevar C, Marchisin D, Wang Z, Chen W, He B, Payne RM, Burns KM, Glatz AC, Male C, Monagle P, Perera V, Murthy B, Merali S.   +17 more
europepmc   +1 more source

Significance of FXa and its receptor PAR2 for the growth of colon cancer cells <i>in vitro</i> and <i>in vivo</i>. [PDF]

Front Oncol
Meyer U, Rönnpagel V, Grammbauer S, von Lucadou M, Rauch-Kröhnert U, Schwedhelm E, Dombrowski F, Ritter C, Rauch BH.   +8 more
europepmc   +1 more source

The Safety of Apixaban Compared to Warfarin in Hospitalized Patients with Acute Kidney Injury. [PDF]

J Clin Med
Al Yami MS, Alfehaid L, Alshehri AM, Alqahtani N, Almuaither G, Alonazi SH, Alzahrani MY, Badawoud AM, Almohammed OA.   +8 more
europepmc   +1 more source